Chemed Corporation (NYSE: CHE) reported Q2 EPS of $3.57, $0.72 worse than the analyst estimate of $4.29. Revenue for the quarter came in at $532 million versus the consensus estimate of $511.85 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.